Press Releases July 30, 2026 04:05 PM

Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference Call

Cibus Announces Second Quarter 2026 Financial Results Release and Conference Call

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
CBUS

Cibus, Inc., a Nasdaq-listed technology company specializing in improving crop traits through proprietary gene-editing, will report its second quarter 2026 financial results on August 13, 2026, and host a conference call to discuss the results and company updates.

Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference Call
CBUS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Cibus helps farmers grow more food with fewer inputs using precise gene-editing technology without adding foreign DNA.
  • The company licenses crop trait improvements to seed companies in exchange for royalties, focusing on higher yields, better quality, and reduced chemical use.
  • Second quarter 2026 financial results will be announced on August 13, 2026, followed by a conference call and webcast for investors and interested parties.

SAN DIEGO, July 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a technology company that helps farmers grow more food with fewer inputs, today announced that the company will report second quarter 2026 financial results on Thursday, August 13, 2026. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.

Title: Cibus, Inc. Second Quarter 2026 Results Conference Call
Event Date: Thursday, August 13, 2026        
Time: 4:30 p.m. ET        
Participant Numbers: +1-800-420-1459 (U.S.), +1-203-518-9861 (International)
The conference ID “CIBUS” or 24287 will be required for entry
Event Link: https://investor.cibus.com/events

For interested individuals unable to join the conference call, a dial-in replay of the call will be available through Thursday, August 27, 2026, and can be accessed by dialing +1-844-512-2921 (U.S.), +1-412-317-6671 (International) and entering replay passcode: 11162209.

A live audio webcast of the call, along with accompanying slides, will be available under "News & Events” in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.

About Cibus

Cibus (Nasdaq: CBUS) is a technology company that helps farmers grow more food with fewer inputs. Using its proprietary platform, Cibus improves a seed company's best crop varieties by making precise changes to the plant's own genes, with no foreign DNA added, then licenses those improvements back to the customer in exchange for royalties. Cibus is not a seed company. It develops crop traits at a fraction of the time and cost of conventional breeding, with a focus on higher yields, better quality, and reduced chemical use. For more information, visit www.Cibus.com.

Cibus Contacts:

Investor Relations
Jeff Sonnek – ICR
[email protected]

Media Relations
Colin Sanford
[email protected]
203-918-4347


Risks

  • Financial results may not meet market expectations, potentially impacting stock performance.
  • The company depends on licensing agreements with seed companies, which may face adoption or regulatory challenges.
  • Agricultural technology and crop trait improvements are subject to regulatory approvals and market acceptance, posing uncertainty.

More from Press Releases

Baker Hughes and Venture Global Advance Next Phase of U.S. Gas Infrastructure Growth Sep 13, 2026 Axe Compute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Sep 11, 2026 EverCommerce Announces an Increase and Extension of its Share Repurchase Program Sep 11, 2026 Grupo Aeroportuario del Pacifico Announces the Execution of Bank Credit Facilities Totaling Ps. 8,000 Million Sep 11, 2026 Eastern International Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency Sep 11, 2026